Advertisement

Topics

$30M deal to acquire CellRight completed by Tissue Regenix

06:50 EDT 10 Aug 2017 | SmartBrief

The approximately $30 million acquisition of CellRight Technologies, along with its spinal surgery and orthopedic portfolio,  -More

Original Article: $30M deal to acquire CellRight completed by Tissue Regenix

NEXT ARTICLE

More From BioPortfolio on "$30M deal to acquire CellRight completed by Tissue Regenix"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...